Table 7:
Potential national cost savings and increase in radiotherapy access with adoption of evidence-based hypofractionated schemes for breast and prostate cancer in sub-Saharan Africa
| National radiotherapy access in 2020 (%)* | Breast cancer (2020–30) |
Prostate cancer (2020–30) |
|||
|---|---|---|---|---|---|
| Projected national cost for full access to breast radiotherapy at conventional fractionation (US$ million) | Projected national cost savings with hypofractionated breast radiotherapy (US$ million) | Projected national cost for full access to prostate radiotherapy at conventional fractionation (US$ million) | Projected national cost savings with hypofractionated prostate radiotherapy (US$ million) | ||
| Angola | 53·0 | 514·3 | 20·7 | 47·1 | 2·3 |
| Benin | 7·1 | 35·7 | 14·1 | 30·0 | 14·3 |
| Botswana | 10·9 | 4·0 | 1·6 | 1·6 | 0·7 |
| Burkina Faso | 6·9 | 34·3 | 13·4 | 15·7 | 7·4 |
| Burundi | 3·1 | 15·7 | 6·0 | 17·1 | 8·3 |
| Cameroon | 77·7 | 757·1 | 30·1 | 48·6 | 22·9 |
| Cape Verde | 0·1 | 1·0 | 0·4 | 1·9 | 0·9 |
| Central African Republic | 2·4 | 12·1 | 4·9 | 6·9 | 3·3 |
| Chad | 7·7 | 38·6 | 15·6 | 12·9 | 6·1 |
| Comoros | 0·2 | 1·0 | 0·4 | 1·1 | 0·6 |
| Côte d’Ivoire | 61·4 | 614·3 | 24·6 | 54·3 | 25·9 |
| Democratic Republic of the Congo | 51·4 | 257·1 | 57·7 | 130·0 | 62·3 |
| Equatorial Guinea | 0·3 | 3·0 | 1·3 | 2·0 | 1·0 |
| Eritrea | 3·4 | 17·1 | 6·9 | 2·0 | 1·0 |
| Eswatini | 0·2 | 1·7 | 0·7 | 1·7 | 0·9 |
| Ethiopia | 71·9 | 357·1 | 142·9 | 37·1 | 18·0 |
| Gabon | 12·3 | 4·0 | 1·6 | 4·1 | 2·0 |
| Ghana | 12·9 | 104·3 | 42·0 | 47·1 | 22·6 |
| Guinea | 0·3 | 1·4 | 5·6 | 20·0 | 9·6 |
| Guinea-Bissau | 0·8 | 3·9 | 1·6 | 1·7 | 0·9 |
| Kenya | 18·1 | 142·9 | 58·3 | 67·1 | 31·9 |
| La Réunion, France | 1·2 | 7·7 | 3·1 | 9·4 | 4·4 |
| Lesotho | 0·3 | 3·1 | 1·3 | 2·6 | 1·1 |
| Liberia | 6·9 | 9·6 | 3·9 | 8·3 | 4·0 |
| Madagascar | 8·2 | 31·4 | 12·6 | 40·0 | 19·3 |
| Malawi | 5·7 | 28·6 | 11·7 | 11·3 | 5·4 |
| Mali | 9·6 | 41·4 | 16·4 | 11·6 | 5·6 |
| Mauritania | 6·3 | 9·4 | 3·9 | 4·7 | 2·3 |
| Mauritius | 21·1 | 13·6 | 5·4 | 4·0 | 2·0 |
| Mozambique | 7·1 | 31·4 | 12·6 | 37·1 | 17·6 |
| Namibia | 19·6 | 7·3 | 2·9 | 4·6 | 2·1 |
| Niger | 8·8 | 38·6 | 15·3 | 4·0 | 2·0 |
| Nigeria | 61·2 | 600·0 | 239·1 | 285·7 | 138·1 |
| Republic of the Congo | 0·9 | 9·1 | 57·7 | 11·6 | 62·3 |
| Rwanda | 5·4 | 27·1 | 10·6 | 17·1 | 8·1 |
| São Tomé and Príncipe | 0·0 | 0·3 | 0·1 | 0·3 | 0·1 |
| Senegal | 12·8 | 41·4 | 16·4 | 21·4 | 10·0 |
| Sierra Leone | 4·6 | 22·9 | 9·4 | 8·4 | 4·0 |
| South Africa | 59·3 | 300·0 | 121·7 | 271·4 | 128·9 |
| South Sudan | 12·3 | 32·9 | 12·9 | 15·7 | 7·6 |
| Tanzania | 15·9 | 71·4 | 28·9 | 97·1 | 46·7 |
| The Gambia | 0·2 | 1·1 | 0·4 | 0·7 | 0·3 |
| Togo | 3·4 | 17·1 | 6·9 | 7·0 | 3·3 |
| Uganda | 12·5 | 57·1 | 22·9 | 47·1 | 22·6 |
| Zambia | 3·5 | 21·4 | 8·7 | 27·1 | 12·9 |
| Zimbabwe | 10·3 | 44·3 | 17·9 | 27·1 | 13·0 |
| Total | NA | 4388·8 | 1093·1 | 1525·3 | 766·6 |
NA=not applicable. *Details of how the national radiotherapy access percentage was calculated are given on p 2 of the appendix.